PRO-DEX, INC. Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months
PRO-DEX, INC. (PDEX) had Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months of $123.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths · last filed 2022-05-05
- 2022-03-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $123.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $246.00K.
- 2021-09-30: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $369.00K.
- 2021-03-31: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $120.00K.
| Period end | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months |
|---|---|
| 2022-03-31 | $123.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $246.00K 10-Q · filed 2022-02-03 |
| 2021-09-30 | $369.00K 10-Q · filed 2021-11-15 |
| 2021-03-31 | $120.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $239.00K 10-Q · filed 2021-02-04 |
| 2020-09-30 | $359.00K 10-Q · filed 2020-11-05 |
| 2020-03-31 | $116.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $232.00K 10-Q · filed 2020-02-06 |
| 2019-09-30 | $348.00K 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |